E-ISSN 0976-2779 | ISSN 0975-8453
 

Review Article 


TSH, FT4, and CD4 Profile in HIV/AIDS Patients Before and After Antiretroviral Fixed-Dose Combination Tenofovir, Lamivudine, Evafirenz Therapy

Djati Susilo, Sony Wibisono, Usman Hadi.

Abstract
HIV infection can cause thyroid abnormality, and the use of Antiretroviral (ARV) can make it worse. The objective of this study was to identify the difference of thyroid profile level in HIV/AIDS before and after fixed-dose combination (FDC) therapy. This was a descriptive longitudinal observational study using one group pretest and posttest comparative design involving 20 samples. The subjects were all HIV/AIDS patients receiving ARV FDC but never received such therapy before. The mean age of the subjects was 32.9▒9.19 years, with a range of 20-50 years. The majority of the subjects were males 15 (75%) and the most risk factor was vaginal sex as much as 11 subjects (55%). TSH and FT4 mean levels before therapy were 1.1▒0.22 ÁIU/ml FT4 and 1.15▒0.17 ng/dl, respectively and after receiving FDC ARV were of 2.34▒1.23 ÁIU/ml and 1.01 ▒ 0.14 ng/dl, respectively. There were significant differences in TSH (p = 0.000), FT4 (p = 0.012), and CD4 (p = 0.000) in HIV/AIDS patients before and after receiving FDC ARV for 3 months. There was a significant difference in thyroid profile before and 3 months after received ARV FDC.

Key words: HIV/AIDS, thyroid profile abnormality, antiretroviral


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Djati Susilo
Articles by Sony Wibisono
Articles by Usman Hadi
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Djati Susilo, Sony Wibisono, Usman Hadi. TSH, FT4, and CD4 Profile in HIV/AIDS Patients Before and After Antiretroviral Fixed-Dose Combination Tenofovir, Lamivudine, Evafirenz Therapy. SRP. 2020; 11(3): 635-639. doi:10.31838/srp.2020.3.85


Web Style

Djati Susilo, Sony Wibisono, Usman Hadi. TSH, FT4, and CD4 Profile in HIV/AIDS Patients Before and After Antiretroviral Fixed-Dose Combination Tenofovir, Lamivudine, Evafirenz Therapy. http://www.sysrevpharm.org//?mno=96059 [Access: June 01, 2020]. doi:10.31838/srp.2020.3.85


AMA (American Medical Association) Style

Djati Susilo, Sony Wibisono, Usman Hadi. TSH, FT4, and CD4 Profile in HIV/AIDS Patients Before and After Antiretroviral Fixed-Dose Combination Tenofovir, Lamivudine, Evafirenz Therapy. SRP. 2020; 11(3): 635-639. doi:10.31838/srp.2020.3.85



Vancouver/ICMJE Style

Djati Susilo, Sony Wibisono, Usman Hadi. TSH, FT4, and CD4 Profile in HIV/AIDS Patients Before and After Antiretroviral Fixed-Dose Combination Tenofovir, Lamivudine, Evafirenz Therapy. SRP. (2020), [cited June 01, 2020]; 11(3): 635-639. doi:10.31838/srp.2020.3.85



Harvard Style

Djati Susilo, Sony Wibisono, Usman Hadi (2020) TSH, FT4, and CD4 Profile in HIV/AIDS Patients Before and After Antiretroviral Fixed-Dose Combination Tenofovir, Lamivudine, Evafirenz Therapy. SRP, 11 (3), 635-639. doi:10.31838/srp.2020.3.85



Turabian Style

Djati Susilo, Sony Wibisono, Usman Hadi. 2020. TSH, FT4, and CD4 Profile in HIV/AIDS Patients Before and After Antiretroviral Fixed-Dose Combination Tenofovir, Lamivudine, Evafirenz Therapy. Systematic Reviews in Pharmacy, 11 (3), 635-639. doi:10.31838/srp.2020.3.85



Chicago Style

Djati Susilo, Sony Wibisono, Usman Hadi. "TSH, FT4, and CD4 Profile in HIV/AIDS Patients Before and After Antiretroviral Fixed-Dose Combination Tenofovir, Lamivudine, Evafirenz Therapy." Systematic Reviews in Pharmacy 11 (2020), 635-639. doi:10.31838/srp.2020.3.85



MLA (The Modern Language Association) Style

Djati Susilo, Sony Wibisono, Usman Hadi. "TSH, FT4, and CD4 Profile in HIV/AIDS Patients Before and After Antiretroviral Fixed-Dose Combination Tenofovir, Lamivudine, Evafirenz Therapy." Systematic Reviews in Pharmacy 11.3 (2020), 635-639. Print. doi:10.31838/srp.2020.3.85



APA (American Psychological Association) Style

Djati Susilo, Sony Wibisono, Usman Hadi (2020) TSH, FT4, and CD4 Profile in HIV/AIDS Patients Before and After Antiretroviral Fixed-Dose Combination Tenofovir, Lamivudine, Evafirenz Therapy. Systematic Reviews in Pharmacy, 11 (3), 635-639. doi:10.31838/srp.2020.3.85